SS
NUVB icon

SBI Securities’s Nuvation Bio NUVB Stock Holding History

SBI Securities’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.41K Buy
1,028
+7
+0.7% +$39 ﹤0.01% 2083
2025
Q4 		$9.15K Buy
1,021
+2
+0.2% +$12 ﹤0.01% 1746
2025
Q3 		$3.77K Buy
1,019
+817
+404% +$2.23K ﹤0.01% 2165
2025
Q2 		$394 Buy
202
+201
+20,100% +$419 ﹤0.01% 3062
2025
Q1 		$2 Hold
1
– – ﹤0.01% 4094
2024
Q4 		$3 Buy
+1
New +$3 ﹤0.01% 4040

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SBI Securities's NUVB Position: Q1 2026 in Review

SBI Securities increased its Nuvation Bio (NUVB) stake by 0.69% in Q1 2026, buying an estimated $39 and bringing the position to 1,028 shares worth $4.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

SBI Securities first reported a position in NUVB in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.15K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • SBI Securities held 1,028 shares of Nuvation Bio worth $4.41K as of Q1 2026.
  • SBI Securities bought 7 Nuvation Bio shares in Q1 2026, an estimated $39.
  • Nuvation Bio made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2083 holding.
  • SBI Securities first reported a position in Nuvation Bio in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Nuvation Bio position peaked at $9.15K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.